Recombitek C4 - 13D1.R1
139 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
139
Total Reports
14
Deaths Reported
1010.0%
Death Rate
Active Ingredients
Recombitek C4 - 13D1.R1
Administration Routes
SubcutaneousUnknownOralIntramuscularRetrobulbar
Species Affected
Dog 139
Most Affected Breeds
Retriever - Labrador 13
Crossbred Canine/dog 11
Retriever - Golden 11
Pit Bull 8
Shih Tzu 8
Dachshund (unspecified) 6
Boxer (German Boxer) 6
Maltese 6
Shepherd Dog - German 4
Pug 3
Most Reported Reactions
Lethargy (see also Central nervous system depression in 'Neurological') 44
Vomiting 42
Diarrhoea 27
Anorexia 20
Other abnormal test result NOS 16
Death 11
Shaking 9
Not eating 9
Pain NOS 7
Seizure NOS 7
Fever 7
Decreased appetite 6
Outcome Breakdown
Outcome Unknown
67 (47.5%)
Recovered/Normal
44 (31.2%)
Ongoing
14 (9.9%)
Died
11 (7.8%)
Euthanized
4 (2.8%)
Recovered with Sequela
1 (0.7%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.